Research & publications
Original research is at the heart of what we do. For more than 60 years, our experts have published across a wide range of topics from the fundamentals of health economics itself to the challenges facing health care in the UK and internationally.
The latest research and publications
Taking STRIDES: The Value of Diagnostics Against AMR
Addressing a critical gap in AMR policy and evaluation Antimicrobial resistance (AMR) is a global health crisis, projected to cause up to 10 million deaths annually…
Altering the Trajectory of HIV in Europe
Despite substantial medical advancements that have transformed HIV into a manageable chronic condition for individuals, the epidemic remains a pressing public health concern in Europe.
Understanding the Full Value of Long-Acting Therapies: less is more?
Long-acting (LA) therapies represent a significant innovation in pharmaceutical development by offering a sustained drug effect with reduced administration frequency.
Understanding the Full Value of Long-Acting Therapies: less is more?
Long-acting (LA) therapies represent a significant innovation in pharmaceutical…
An Analysis of NICE’s Optimised Decisions from 2015 to 2024
The National Institute for Health and Care Excellence (NICE) is the body…
Analysing Global Immunisation Expenditure
Immunisation programmes are foundational to public health. Organised by health…
The BRAVER Roadmap to Broader Assessment of the Value of Health Interventions in the Asia-Pacific Region
Health Technology Assessment (HTA) agencies evaluate and make decisions on the…
Challenges and Solutions for Budget Impact Analysis of Gene Therapies
Gene therapies represent a paradigm shift in medicine, offering the potential…
The Importance of Diversity of Supply in Rare Diseases Markets
Rare disease medicine markets often rely on single suppliers, increasing the…
2023 OHE Annual Report to the Charity Commission
We are pleased to submit our seventh submission to the Charity Commission for…
Employer Costs from Respiratory Infections
Our latest research shows respiratory infections cost UK businesses £44 billion…
Understanding societal preferences for priority by disease severity in England & Wales
How does NICE’s severity modifier work? NICE implemented a new severity…
The Cost of Drug Shortages
Across the globe, drug shortages are becoming increasingly common.